| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A confirmatory factor analysis approach was found to accurately estimate the reliability of transition ratings
|
Griffiths, Pip
|
|
|
141 |
C |
p. 36-45
|
artikel
|
| 2 |
A few panel members dominated guideline development meeting discussions: Social network analysis
|
Li, Shelly-Anne
|
|
|
141 |
C |
p. 1-10
|
artikel
|
| 3 |
A new phenomenon in medical publishing: the autonomous citation
|
Chambers, Geoffrey K.
|
|
|
141 |
C |
p. 210
|
artikel
|
| 4 |
A review found small variable blocking schemes may not protect against selection bias in randomized controlled trials
|
Clark, Laura
|
|
|
141 |
C |
p. 90-98
|
artikel
|
| 5 |
Around ten percent of most recent Cochrane reviews included outcomes in their literature search strategy and were associated with potentially exaggerated results: A research-on-research study
|
Tsujimoto, Yasushi
|
|
|
141 |
C |
p. 74-81
|
artikel
|
| 6 |
A taxonomy and framework for identifying and developing actionable statements in guidelines suggests avoiding informal recommendations
|
Lotfi, Tamara
|
|
|
141 |
C |
p. 161-171
|
artikel
|
| 7 |
Clinical epidemiology challenges when involving patients
|
Tugwell, Peter
|
|
|
141 |
C |
p. A5-A6
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
141 |
C |
p. IFC
|
artikel
|
| 9 |
Elixhauser outperformed Charlson comorbidity index in prognostic value after ACS: insights from a national registry
|
Zhang, Fangyuan
|
|
|
141 |
C |
p. 26-35
|
artikel
|
| 10 |
Estimating power for clinical trials with Patient Reported Outcomes - using Item Response Theory
|
Hu, Jinxiang
|
|
|
141 |
C |
p. 141-148
|
artikel
|
| 11 |
Evidence Based Social Science in China Paper 2: The History and Development of Evidence Based Social Work in China
|
Bai, Zheng-Gang
|
|
|
141 |
C |
p. 151-156
|
artikel
|
| 12 |
Evidence Based Social Science in China Paper 3: The quality of social science RCTs published from 2000–2020
|
Li, Xiuxia
|
|
|
141 |
C |
p. 64-73
|
artikel
|
| 13 |
Evidence Based Social Science in China Paper 4 : The quality of social science systematic reviews and meta-analysis published from 2000-2019
|
Bai, Zheng-Gang
|
|
|
141 |
C |
p. 132-140
|
artikel
|
| 14 |
Evidence-based social sciences in China Paper 1 : Introduction. Howard White
|
White, Howard
|
|
|
141 |
C |
p. 149-150
|
artikel
|
| 15 |
Focus groups and interviews with the public led to the development of a template for a GRADE Plain Language Recommendation (PLR)
|
Santesso, Nancy
|
|
|
141 |
C |
p. 18-25
|
artikel
|
| 16 |
Key concepts in clinical epidemiology: reporting on the accuracy of continuous tests
|
Kohn, Michael A.
|
|
|
141 |
C |
p. 157-160
|
artikel
|
| 17 |
Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: A concept paper
|
Iannizzi, Claire
|
|
|
141 |
C |
p. 82-89
|
artikel
|
| 18 |
More work needed on decision analysis for shared decision-making: A scoping review
|
Humphries, Brittany
|
|
|
141 |
C |
p. 106-120
|
artikel
|
| 19 |
Randomized control trial of unconditional versus conditional incentives to increase study enrollment rates in participants at increased risk of lung cancer
|
Kumar, Anjali D.
|
|
|
141 |
C |
p. 11-17
|
artikel
|
| 20 |
Regression discontinuity analysis for pharmacovigilance: statin example reflected trial findings showing little evidence of harm
|
Scott, Lauren
|
|
|
141 |
C |
p. 121-131
|
artikel
|
| 21 |
Reliability of the revised Cochrane risk-of-bias tool for randomised trials (RoB2) improved with the use of implementation instruction
|
Minozzi, Silvia
|
|
|
141 |
C |
p. 99-105
|
artikel
|
| 22 |
Reporting transparency and completeness in trials: Paper 1: Introduction - Better reporting for disruptive clinical trials using routinely collected data
|
Hemkens, Lars G.
|
|
|
141 |
C |
p. 172-174
|
artikel
|
| 23 |
Reporting transparency and completeness in trials: Paper 4 - reporting of randomised controlled trials conducted using routinely collected electronic records – room for improvement
|
McCall, Stephen J.
|
|
|
141 |
C |
p. 198-209
|
artikel
|
| 24 |
Reporting transparency and completeness in Trials: Paper 2 - reporting of randomised trials using registries was often inadequate and hindered the interpretation of results
|
Mc Cord, Kimberly A.
|
|
|
141 |
C |
p. 175-186
|
artikel
|
| 25 |
Reporting transparency and completeness in trials: Paper 3 – trials conducted using administrative databases do not adequately report elements related to use of databases
|
Imran, Mahrukh
|
|
|
141 |
C |
p. 187-197
|
artikel
|
| 26 |
Response to “Should We Formalise the Assessment of Clinical Heterogeneity/Diversity In Systematic Reviews” - clarifications of the use of the CDIM tool to assess clinical heterogeneity/diversity in meta-analyses
|
Barbateskovic, Marija
|
|
|
141 |
C |
p. 211
|
artikel
|
| 27 |
Sample size considerations are needed for the causal analyses of existing databases
|
Mansournia, Mohammad Ali
|
|
|
141 |
C |
p. 212
|
artikel
|
| 28 |
Secondary electronic sources demonstrated very good sensitivity for identifying studies evaluating interventions for COVID-19
|
Pierre, Olivier
|
|
|
141 |
C |
p. 46-53
|
artikel
|
| 29 |
Specific body mass index trajectories were related to musculoskeletal pain and mortality: 19‐year follow‐up cohort
|
Radojčić, Maja R.
|
|
|
141 |
C |
p. 54-63
|
artikel
|
| 30 |
Table of Contents
|
|
|
|
141 |
C |
p. A2-A4
|
artikel
|
Tijdschrift beschrijving